Back

Identification of founder MYBPC3 gene mutations in hungarian patients with hypertrophic cardiomyopathy

25 May 2019 (08:30 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Annamaria Tringer

University of Szeged, Szeged (Hungary)

34 More presentations in this session

Presentation thumbnail
Doctor J. Lupon (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Doctor H. Froehlich (Heidelberg, DE)
Abstract
Presentation thumbnail
Associate Professor D. Castagno (Turin, IT)
Abstract
Presentation thumbnail
Doctor T. Furlan (Trbovlje, SI)
Abstract Slides
Presentation thumbnail
Professor E. Omerovic (Gothenburg, SE)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2019

25 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Phenotypic spectrum of a Belgian pathogenic founder variant in MYBPC3
21 May 2023
thumbnail
Webinar
Diagnosis and management of hypertrophic cardiomyopathy
5 December 2023
thumbnail
Congress Presentation
The genetic architecture of dilated cardiomyopathy in Hungary: analysis of 135 patients with a panel of 98 genes
13 May 2024
thumbnail
Congress Presentation
Prevalence of MYL2 and MYL3 rare variants among patients with hypertrophic cardiomyopathy in Hungary
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources